GCN2 kinase activation by ATP-competitive kinase inhibitors
Colin P. Tang, Owen Clark, John R. Ferrarone, Carl Campos, Alshad S. Lalani, John D. Chodera, Andrew M. Intlekofer, Olivier Elemento, Ingo K. Mellinghoff
Topics & Concepts
NeratinibKinaseErbBCancer researchCell biologymTORC1BiologyChemistrySignal transductionCancerGeneticsPI3K/AKT/mTOR pathwayTrastuzumabBreast cancerProtein Degradation and InhibitorsMelanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer